de Haas RJ, Lim C, Ricci C, et al. - Individuals (n = 182) who underwent liver transplant for hepatocellular carcinoma (HCC) at a single tertiary referral center between 2008 and 2016 were involved and retrospectively investigated by the experts in order to determine the potential impact of local ablation of HCC on liver transplant outcomes. Prior to the liver transplant, 26 individuals underwent resection but not local ablation. Out of 156 individuals left, 66 underwent local ablation former to the liver transplant and 90 did not. In both groups, prior to and following propensity score matching, perioperative mortality and morbidity were comparable. Moreover, between the groups, former and subsequent to propensity score matching, there were no important variations in long-term outcomes. Also, in the local ablation group vs the liver resection group, no variations were noted in outcomes. Thus, local ablation prior to the liver transplant does not have a negative impact on outcomes following liver transplant for HCC.